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A B S T R A C T
Objective: Epstein-Barr virus (EBV) is a ubiquitous human γ-herpes virus, which can adapt 
and evade host immune defense. Dendritic cells (DCs) play a pivotal role in the initiation 
and maintenance of immune responses. This study investigated the effects of EBV on cord 
blood monocytes derived DCs (CBDC). 
Methods: Monocytes were isolated from cord blood and cultured in medium containing 
recombinant IL-4 and GM-CSF to induce DCs development. B95-8 supernatant was added 
in monocytes culture medium for EBV infection at day 0. Phenotypic characterization of 
DCs, apoptotic cells, and mitochondrial membrane potential (MMP) were detected by flow 
cytometry. The morphology was observed by Hoechst 33258 staining and TUNEL staining, 
the expression of X-linked inhibitor of apoptosis protein (XIAP) was detected by Western 
blotting assay and caspase 3, 8 and 9 activity was measured. 
Results: Phenotypic characterization of DCs was changed in EBV-treated group. Chromatin 
condensation and DNA fragmentation were observed in EBV induced CBDC apoptosis. In 
addition, caspase 3, caspase 8, and caspase 9 activation were enhanced in the EBV-treated 
group. This was accompanied by the loss of MMP. Furthermore, XIAP expression was down-
regulated in the EBV-treated group and compared to mock-infected group. 
Conclusion: These results suggested that EBV could inhibit CBDC phenotypic differentiation, and 
induce CBDC apoptosis in caspase-dependent manner with involvement of the mitochondrial 
pathway. This might help EBV to evade host immune responses to establish persistent infection.
Introduction
Epstein-Barr virus (EBV) is a ubiquitous human γ-herpes 
virus present in 90% of the world population. Primary EBV 
infection is usually asymptomatic at an early age. The infected 
individuals harbor the virus without further expression of 
clinical symptoms. Under certain conditions, EBV infections 
may also be associated with the development of malignancies, 
such as nasopharyngeal carcinomas, lymphoproliferative 
syndrome of immunocompromised patients and with 
some lymphomas (Burkitt’s lymphoma, Hodgkin’s lymphoma 
or T cell lymphoma).1,2 
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Dendritic cells (DCs) are antigen-presenting cells that play 
key roles in linking innate and adaptive immunity. DCs 
play a crucial role in anti-viral immune responses. DCs might 
also be involved in the immune escape mechanisms of EBV. 
The relationship between EBV and DCs remains unclear, 
although more and more evidence has accumulated. CD14+ 
monocytes can be induced to differentiate into DCs both in 
vitro and in vivo, indicating divergent pathways for monocytes 
differentiation.
The outcome of EBV infection is dependent on the monocyte 
maturation state. Recently, Li et al.3 have demonstrated that 
EBV infection inhibits the development of DCs by promoting 
apoptosis of their monocyte precursors cultured with 
granulocyte-macrophage colony-stimulating factor (GM-CSF) 
and IL-4. Thus, modulation of monocytes survival and 
maturation may represent an important strategy used by EBV 
to interfere with virus-specific immune responses.
Apoptosis plays an important role in host immune 
response to viral infection and is an efficient mechanism 
for killing infected cells containing virion spillage. Apoptosis 
will be favored by the virus to enhance virus fitness. Several 
experiments have shown that EBV is associated with altered 
regulation of cell differentiation or apoptosis.4 However, there 
are few reports concerning the activity of human cord blood 
dendritic cells (CBDC). 
In this study, the potential of human CBDC, generated from 
umbilical cord blood monocytes in the presence of GM-CSF and 
IL-4, was analyzed. The results demonstrated that EBV could 
infect monocytes and inhibit their differentiation into DCs. EBV 
induced cell death in vitro, and the cell death was associated 
with nucleosomal cleavage of cellular DNA and expression of 
phosphatidylserines on cell surface, an early event of apoptosis 
occurring before membrane disruption. We demonstrated 
that EBV-induced apoptosis was dependent on activation of 
caspases. These findings might help us well understand the 
immunoregulation and pathogenesis of EBV infection. 
Materials and methods
Isolation of monocytes 
Human umbilical cord blood samples were collected from 
normal, full-term infants. Informed consent was obtained 
from the mothers prior to delivery. The protocol was 
approved by Institutional Review Board of Xinhua Hospital. 
All cord blood samples were collected in heparinized flasks. 
Cord blood mononuclear cells were isolated from whole 
blood using Ficoll-Hypaque gradients (Hengxin Chemical 
Reagent Co., Ltd, Shanghai, China). Mononuclear cells at 
the interface were collected, washed twice with PBS, then 
cells were plated at a density of 1×106 cells/mL in complete 
culture medium (RPMI 1640 supplemented with 10% heat-
inactivated fetal calf serum, 2 mM L-glutamine, 1 mM 
sodium pyruvate, 10 mM Hepes, 100 U/mL penicillin and 
100 U/mL streptomycin) on plastic plates and incubated at 
37°C, 5% CO2 for 2 hours. The adherent cells were detached 
with cell scraper. Cell viability, was measured using trypan 
blue exclusion. If viability was more than 95%, cells could 
be harvested. The purity of monocytes (CD14+ cells) was 
measured by flow cytometry. If purity was more than 90%, 
cells could be harvested. 
Generation of immature DCs in vitro
Detached monocytes (1×106 cells/mL) were maintained 
in complete culture medium containing IL-4 (10 ng/mL, 
PeproTech, USA) and GM-CSF (50 ng/mL, PeproTech, USA) 
and incubated in a humidified incubator with 5% CO2 at 37°C. 
The cultures were fed with fresh medium and cytokines every 
3 days. Cell differentiation was monitored by light microscopy.
Virus preparation, titration and infection 
EBV was obtained from culture supernatants of B95-8 cell 
line. Briefly, B95-8 cells were incubated in RPMI-1640 medium 
supplemented with 10% heat-inactivated fetal bovine 
serum. The viability of cells was determined by trypan blue-
dye exclusion. When the viability reached 20% or less, the 
cell culture supernatant was harvested, and filtered 
through a 0.22 μm pore size filter. The virus was purified by 
ultracentrifugation at 16000xg for 90 min at 4°C. Virus stocks 
were resuspended in RPMI-1640, aliquoted and frozen at 
-70°C until use. EBV infection was performed by resuspending 
EBV preparation in 1×106 monocytes (1:2v/v). This was set as 
the 0 day point of infection (POI) for the experiments described 
below. After incubation for 1 h at 37°C, cells were washed with 
PBS and cultured in medium contained IL-4 and GM-CSF to 
induce DCs development. Mock infected cells were treated in 
parallel, without virus. 
Immunofluorescence staining 
After a 7-day culture as described above, cells were mixed 
with fluorochrome-conjugated antibodies (CD14-FITC, 
CD40–FITC, CD80-FITC, CD83-FITC, CD86-FITC, MHC class 
I-FITC, MHC class II-FITC, CD11c-PE, MR-PE, and CD1a–PC5, 
HLA-DR-PC5) at a concentration of 4 μg/106 cells and incubated 
in dark for 15 min. After incubation, cells were resuspended in 
300 μL PBS and analyzed by flow cytometry (FACSCalibur, 
Becton Dickinson, USA). Control cells were stained with 
isotype-matched antibodies. The proportions of positive cells 
were calculated using CellQuest software. FITC, PE and PC5 
conjugated antibodies were all from BD PharMingen (San 
Diego, CA, USA). 
Apoptosis assay by flow cytometry 
Cells were gently scraped and collected from the wells at the 
defined time. The percentage of cells undergoing apoptosis 
was detected by using the Annexin V (AV)-FITC Apoptosis Detection 
Kit (BioVision, USA). Cells were resuspended in 1×binding 
buffer at a concentration of 1×106 cells/mL. A volume of 
100 μL of solution containing 1×105 cells was incubated with 
5 μL of AV-FITC and 5 μL of propidium iodide (PI) for 15 min at 
room temperature in the dark, followed by addition of 400 μL 
of 1×binding buffer. Samples were analyzed by flow cytometry 
within 1 hour. 
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Measurement of nuclear morphology by Hoechst 33258 staining 
Cells were harvested on day 7. Briefly, cells were fixed with 
4% paraformaldehyde for 30 min and washed three times 
with PBS. Then cells were exposed to 10 mg/L Hoechst 33258 
(Beyotime, China) in the dark at room temperature for 10 
min. Morphologic changes in apoptotic nuclei were observed 
under fluorescence microscope with excitation at 350 nm and 
emission at 460 nm. The cells with condensed chromatin 
and shrunken nuclei were classic as apoptotic. The apoptotic 
percentage was calculated by counting the number of apoptotic 
cells in three different fields per slide. At least three slides were 
counted.
Measurement of DNA fragmentation using the TUNEL assay
To detect cells containing DNA fragments, the TUNEL (TdT-
mediated dUTP nick-end labeling) method was employed. 
EBV-infected or mock-infected DCs were harvested on day 
7 post infection. The FITC-labeled TUNEL-positive cells 
were stained with the One Step TUNEL Apoptotic Assay Kit 
(Beyotime, China) according to the manufacturer’s instruction. 
All samples were detected by fluorescence microscope. Three 
randomly areas per slide were used to calculate the rate of 
apoptotic cells. At least three slides were counted.
Caspase 3, 8 and 9 activity assay 
Caspase activity was determined on the basis of transformed 
ability of caspase 3, 8 and 9 (Beyotime, China). Cells were 
lysed in a lysis-buffer (100 μL per 2×106 cells ) for 15 min 
on ice. The cell lysate was centrifuged at 12000xg for 
15 min at 4°C and the precipitates were discarded. Protein 
concentrations were measured by the Bradford Protein Assay 
Kit (Beyotime, China). The mixture composed of 10 μL of cell 
lysate, 80 μL of reaction buffer and 10 μL of 2 mM caspase 
substrate (for -8,-9, and -3) was incubated in 96-well plate 
at 37°C for 2 hours. Caspase activity was quantified by a 
microplate spectrophotometer (Biotek, USA) at 405 nm. The 
specific caspase activity, normalized for total proteins of cell 
lysate, was then expressed as fold of the baseline caspase 
activity of control cells.
Detection of XIAP by Western blot analysis 
X-linked inhibitor of apoptosis protein (XIAP) was 
quantified by Western blotting analysis. Briefly, total 
proteins were prepared by standard procedures and 
quantified by Bradford Protein Assay Kit (Beyotime, China). 
Equal amounts of protein (10 μg) from each sample were 
loaded to electrophoresis on a 10% SDS/PAGE gel. Separated 
protein was transported onto nitrocellulose membrane. 
The membrane was incubated with antibody against 
XIAP (1:1000, MBL, Japan) overnight at 4°C. After washing, 
the membrane incubated with horseradish peroxidase-
conjugated goat anti-mouse IgG before detection using 
the ECL chemoluminescence system. Membranes were 
probed for β-actin to normalize for equal protein loading 
and transfer.
Measurement of mitochondrial membrane potential 
Mitochondrial membrane potential (MMP) was measured 
by the retention of Rhodamine 123 (Rh123), a membrane-
permeable fluorescent cationic dye. The uptake of RH123 
by mitochondria is proportional to the MMP. Briefly, 
cells were adjusted to a density of 106/mL in PBS. 150 μL 
Rh123 (1 μg/mL, Sigma, USA) was added to 150 μL of the cell 
suspension while 150 μL PBS was added to another 150 μL 
cell suspension as a negative control. The cell suspensions 
were incubated at 37°C for 30 min, and then cells were 
washed with PBS and analyzed by flow cytometry. 
The relative fluorescence intensity (RFI) was determined 
by: [MFI (mean fluorescence intensity) of the stained 
group] / [MFI of the unstained group] 
Statistical analysis 
All data were expressed as mean ± SD. Statistical analyses 
were processed with SPSS 11.5 statistical software program. 
Student’s t test was performed between EBV-infected DCs and 
mock-infected DCs. Significant differences were indicated as 
*p < 0.05 and **p < 0.01.
Results 
Surface molecule expressions on CBDC stimulated with EBV
Immunophenotypic studies were performed on CBDC generated 
from purified monocytes cultured with IL-4 and GM-CSF. After 7 
days of culture, the cells exhibited characteristic DCs morphology 
and surface molecule expressions. Flow cytometric analysis 
identified DCs as CD11c+, CD1a+, CD14- cells (Fig. 1). They did 
not express monocyte surface maker, CD14, indicating that 
monocytes were induced to DCs. After EBV treatment, CD14 
expression did not decrease completely. A lower percentage of 
CD1a+ cells, a marker of immature monocyte-derived DCs, was 
generated from the EBV-treated group. There was no difference 
in the percentages of CD11c+ cells generated from control and 
EBV-treated groups. The percentage of mannose receptor (MR)-
positive cells in EBV-treated DCs was also significantly lower than 
that in cord blood DCs. However, CD40, CD83 and CD86 on the 
EBV-treated group could be up-regulated markedly (Fig. 2).
EBV induced CBDC apoptosis 
To investigate the apoptotic rate of EBV induced apoptosis, CBDC 
were double stained with Annexin V and PI at the indicated 
time. As shown in Fig. 3, the stained cells were divided into 
three groups: cells in the AV-/PI- subgroup were intact cells; 
cells in the AV+/PI- subgroup were apoptotic cells; cells in the 
AV+/PI+ subgroup were necrotic cells. No significant changes 
were observed in the control group at days 5, 6, and 7. In contrast, 
EBV treatment led to a slight but significant increase in apoptotic 
incidences on day 6 after infection, specifically enhancing DC 
apoptosis in a time-dependent manner. There was no significant 
difference in the percentage of AV+/PI+ double positive cells 
between the control and the EBV-treated groups.
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Fig. 1 - Mock-infected immature DCs and EBV-infected 
immature DCs were cultured for 7 days. Expression levels of 
CD14, CD11c and CD1a in mock-infected immature DCs and 
EBV-infected immature DCs were examined by three-color 
flow cytometry. (A) Phenotypic characterization of the cord 
blood monocyte-derived dendritic cells in a representative 
case. (B) Comparison of percentages of CD14-, CD1a- and 
CD11c- positive cells between control and EBV-treated 
cord blood monocytes after a 7-day culture with GM-CSF 
and IL-4. Significantly lower CD1a+ and higher CD14+ cells 
were found in EBV-treated group than in the control group. 
Results are expressed as mean ± SD, n = 8. *p < 0.05.
Fig. 2 - Expression levels of CD40, CD80, CD83, CD86, MHC 
class I, MHC class II and MR molecules on control DCs 
and EBV-treated cord blood DCs. CD40, CD83 and CD86 
were higher in EBV-treated cord blood DCs compared to 
control DCs, while MR was lower in EBV-treated cord blood 
DCs compared to control DCs. Statistical significance was 
confirmed in 8 experiments. Results are expressed as 
mean ± SD, n = 8. Compared with control, *p < 0.05.
Fig. 3 - DCs viability and apoptosis percentage were analyzed 
by flow cytometry on three different days after infection (days 5, 
6, and 7). Only the AV+/PI- cells were gated as apoptotic cells. * 
mean p < 0.05 compared with control group (mean ± SD, n = 8).
EBV-induced nuclear condensation and DNA fragmentation 
Cells undergoing apoptosis show a sequence of morphological 
features, such as chromatin condensation and DNA 
fragmentation. Chromatin condensation of apoptotic 
cells was detected by Hoechst 33258 staining. After 7 days 
of culture, the two groups had a homogeneous pattern of 
staining for Hoechst 33258. The nuclei of control group 
appeared with regular contours and were round or ellipse 
in shape. In contrast, many cells with smaller nuclei and 
condensed chromatin were observed in EBV-treated group 
(Fig. 4). DNA fragmentation was detected by TUNEL staining. 
Many yellowish green TUNEL-positive cells were observed in 
EBV-treated group (Fig. 4), while very few TUNEL-positive cells 
were observed in the control group. These data show that 
EBV induced monocytes derived DCs death in apoptotic way. 
Caspases activation in EBV-mediated apoptosis 
Caspases, a family of cysteine proteases, play an important 
role in the execution phase of apoptosis. To assess the 
activation of caspase 3, 8, 9 in EBV-mediated apoptosis, cells 
were treated with EBV for up to 7 days. Whole cell extracts 
were obtained on days 5, 6, and 7. The activation of caspase 
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Fig. 4 - Morphological changes of DCs on day 7 culture (×400). (A) DCs were stained with Hoechst 33258, and nuclei were 
imaged. There are visible condensed nuclei (red arrows) (B) TUNEL assay showed that EBV-induced DNA fragmentation 
(red arrows). (C) Analysis of Hoechst 33258 staining and TUNEL assay. Apoptotic rate was determined by comparing the 
number of apoptotic cells to the total cells. Compared with control * p < 0.05.
Fig. 5 - Activity of caspase 3, 8, and 9 is assessed on three different days after EBV infection (days 5, 6, and 7). *p < 0.05, 
(mean ± SD, n = 8).
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3, 8, 9 in EBV-treated group were similar to control group 
at day 5. Whereas, caspase 3, 8, 9 activity was increased 
progressively during the following days. No such cleavage 
was observed in the control cells (Fig. 5). These data indicate 
that activation of caspase family of proteases was, at least in 
part, associated with EBV-induced apoptosis.
Down–regulation of XIAP expression 
To further confirm that caspases were activated in EBV-
induced apoptosis, we assessed XIAP expression. DCs were 
treated with EBV for up to 7 days. XIAP level was analyzed 
by Western blotting. As shown in Fig. 6, XIAP was markedly 
decreased in EBV treated group compared to  control cells. 
Fig. 6 - The expression of XIAP was detected by Western 
blot on day 7. Mock-infected immature DCs and EBV- 
infected immature DCs were cultured with GM-CSF and 
IL-4 for 7 days. Then cells were harvested, and total 
proteins were extracted. XIAP were analyzed by Western 
blot. β-actin were normalized for equal protein loading.
Fig. 7 - Mitochondrial membrane potential was detected by 
flow cytometry on three different days after infection (days 
5, 6, and 7).
Mitochondrial alterations in EBV-induced apoptosis 
Changes in the membrane potential of mitochondria 
occur in the early phase of apoptosis. To examine the 
role of mitochondria in EBV-mediated apoptosis, MMP 
was monitored by mitochondria sensitive dye, Rh123, and 
analyzed by flow cytometry. As shown in Fig. 7, mitochondria 
of untreated control cells retained the ability to take up 
Rh123. However, the MMP of DCs derived from EBV-treated 
monocytes significantly decreased from day 5 to day 7 in a 
time-dependent manner.
Discussion 
Despite the fact that monocytes/DCs constitute the key 
elements in nonspecific and specific immune defenses 
against viral infection, very little is known about the 
interactions of EBV with these cell types. Few studies of 
human neonatal DCs in umbilical cord blood have shown 
them to be immunocompetent as they can stimulate a mixed 
leukocyte reaction, although these responses tend to be 
reduced when compared with adult peripheral blood DCs.5 
We have previously demonstrated that CB monocytes can 
be infected by EBV as shown by the expression of EA and 
VCA and BcLF-1, BALF-2, and LMP1 mRNA expression (data 
not shown). Our results suggested that EBV infection could 
alter biological functions of cord blood monocytes and affect 
development to CBDC, which might be a new mechanism 
to disrupt the immune response and promote viral 
propagation during the early stages of infection.
It is different in susceptibility to EBV treatment between 
monocytes and DCs, indicating phenotypical alterations 
during monocyte differentiation into DCs. Immature DCs can 
be identified by their expression of HLA class I and II molecules, 
CD1a, CD40, CD80 and CD86, but not CD83. Mature DCs express 
CD83 and have enhanced HLA class I and II, CD80 and CD86. 
Some researchers have introduced semi-mature DCs and 
pathogen-driven regulatory mature DCs. The characteristics of 
semi-mature DCs are high expression of co-stimulatory molecules 
and CCR7, low excretion of cytokines, which have been related 
to immune tolerance and homeostasis.6 The characteristics of 
pathogen-driven regulatory mature DCs are high expression 
of co-stimulatory molecules and CCR7, down-regulation of 
IL-12 secretion and up-regulation of IL-10 secretion, which 
have been related to protection of host and immune evasion 
of pathogens.7-12 According to the phenotype, EBV-infected 
DCs in our culture system were similar to the two kinds of DCs 
mentioned above, which showed mature phenotype and down-
regulation of MR expression, with inhibition of differentiation and 
without enhancement of antigen presenting capacity. 
DCs are critical for efficient induction of primary immune 
responses and inhibition of their function is likely to delay the 
development of both cellular and humoral specific immunity 
in EBV-infected individuals. EBV latent membrane protein 1 
(LMP-1) protects infected B cells from apoptosis by up regulation 
of the bcl-2. EBNA-2, another EBV latent protein, can increase 
the effect of LMP-1 on bcl-2 expression. Bcl-2 is anti-apoptosis 
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protein.13,14 This mechanism does not seem to be used by 
EBV with regard to DCs, because EBNA-2 protein was not 
detected in DCs; moreover, expression bcl-2 and bcl-x are 
likely to be absent in this type. EBV-induced apoptosis of DCs 
is a complex phenomenon necessitating multiple events. 
Although enormous strides made in our understanding of 
cell death, the mechanism by which EBV cause apoptosis is 
still unknown.
Viral counterattack could lead to immunosuppression. It 
could be particularly efficient if it targets DCs, which play a 
pivotal role in both innate and adaptive immune responses. 
In this study, we investigated whether EBV might induce 
apoptosis in DCs derived from cord blood monocytes. We 
dectected apoptotic DCs by staining with Annexin V and 
PI. Our results demonstrated that EBV could induce CBDC 
apoptosis. EBV induced DCs apoptosis which was dependent 
on caspase activation. We also found that caspase 3, 8, 
and 9, which belong to the class of proteases involved in 
apoptosis, were activated. Mitochondrial contribution was 
validated by MMP loss during apoptosis. We also assessed 
MMP in apoptotic DCs. The loss of MMP in EBV-treated 
group suggested that mitochondrion might modulate at 
an early stage the EBV-mediated death signal. Our findings 
thus suggested that, in addition to the inhibition of DCs 
maturation, the immunosuppressive effects of DCs are 
mediated, at least in part, by inducting DCs apoptosis.
There are two distinct pathways of cell death leading 
to caspase activation, as already reported. Mitochondrial 
proteins that cause caspase-dependent cell death include 
cytochrome C (Cyt C), which triggers caspase-9 activation 
by binding and activating the apoptotic protease activating 
factor-1 (Apaf-1), and Smac/Diablo, which potentiates 
caspase activation by binding inhibitor of apoptosis proteins 
(IAP) and blocking their caspase-inhibitory activity. 
Caspase-3 is activated during most apoptotic processes and 
is believed to be the main executioner caspase.15 Its activation 
has been shown to be essential for DNA fragmentation as 
well as chromatin condensation and plasma membrane 
blebbing. Biochemically, these alterations are associated with 
the translocation of phosphatidylserine to the outer leaflet 
of the plasma membrane and the activation of an 
endonuc lease  which  c leaves  genomic  DNA into 
internucleosomal fragments. The conserved IAP family of 
proteins can potently inhibit the enzymatic activity of active 
caspases. In mammals, caspase-3, -7 and -9 are subject to 
inhibition by IAPs. Interestingly, although caspase-9 binds 
to several IAPs, it is primarily inhibited by XIAP. By contrast, 
caspase-3 and -7 are inhibited by XIAP and to a lesser extent, 
by c-IAP1, c-IAP2 and NAIP.16,17 XIAP almost disappeared in 
EBV-treated group compared to the control group.
Our results suggested the involvement of different 
pathways for the differential regulation of co-stimulatory 
molecule expression and apoptosis. DCs maturation and 
survival are regulated by different signaling pathways, as 
previously described.18
In this study, we have compared the outcomes of EBV 
infected and mock-infected monocytes on the development 
of primary human dendritic cells, important antigen-
presenting cells for initiating adaptive immune responses. 
EBV not only inhibited the maturation of cord blood 
monocyte-derived DCs but also promoted the apoptosis of 
CBDC. It might be one strategy that EBV evades host immune 
responses to establish persistent infection.
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